Keystone Symposia Convenes Virtual ePanel on Tech Transfer


Keystone Symposia will on Wednesday, 14th February 2018 host a free ePanel discussion on the topic of “Tech Transfer for Medical Advances: Challenges and Opportunities in Commercializing Academic Biomedical Research ” from  12:00 PM ET, 17:00 GMT. The 90  minute event will be broadcast globally and will include a 30 – minute audience Q&A session. The event is open to everyone with online registration required.

Audience members can submit a question for the panel when they register or during the event broadcast via the chat room. The panel will be moderated by Dr. Juan Carlos Lopez , formerly editor of Nature Medicine and Nature Reviews Neuroscience, then Head of Academic Relations and Collaborations at Roche, and now founder and president of Haystack Science.

Panelists  consist of Lita Nelsen,  recently retired from her position for 30 years as the Director of Technology Licensing Office at the Massachusetts Institute of Technology; Dr. Curtis Keith; Chief Scientific Officer of Harvard University’s Blavatnik Biomedical Accelerator ; Dr. Katherine Bowdis h Head of Sanofi’s Sunrise Ventures; and Dr. A vi D. Spier, Director of Business Development and Licensing at Novartis Institutes for BioMedical Research.

Drawing on the panel’s expertise from both sides of the table, pharma and academia, the discussion will focus on keys to success as well as obstacles in the process of translating basic research discoveries into therapies that can improve health and patients’ lives. According to Dr. Lopez, “ Factors ranging from too much secrecy and confidentiality to unrealistic expectations of pay – offs and timelines can impede academic – industry collaborations in biomedical research . The panelists will share their own experiences and advice to break down some of these barriers.”

The Keystone Symposia’s new “Virtual Keystone Symposia” format is a way to hold short symposia and panel discussions on timely topics that can benefit from an accelerated production schedule. The format also serves as a way to share the scientific insights gained with a more extensive global audience than those who can attend face – to – face conferences

To date since this new programming  model was launched about four years ago, more than 6,000 people have participated in Virtual Keystone Symposia events, which have been held on diverse topics including neuroscience, genome editing, noncoding RNAs, malaria, multiple sclerosis , neuroinflammation and reproducibility in science.

Leave a Comment